Welcome to Georgia Tech Research Projects

This site is designed to provide a centralized location for all projects inside of the Georgia Tech community related to the Covid-19 response. This site allows users to filter and sort through the database and glean pertinent information about projects of interest. If perhaps you are looking to collaborate with others doing research in a similar or mutually beneficial area of research, start here as this site is designed to promote cross-campus collaboration.

 

Visitors to the site can start by viewing all projects. You will be able to sort and filter to predefined categories for ease of navigation.

View All Projects

Interactive Dashboard

We now have an interactive dashboard that can display project data for our categories. 

Recently Updated

Status
In Progress

Currently, the community prevalence of Covid-19, which is related to herd immunity, is relatively unknown. This project has identified crowdsource tracking as a possible solution.

Self-reporting of symptoms may estimate prevalence independent of widespread testing. The website CountCOVID.org askes individuals to answer a six–question survey that will collect symptom data — anonymously and securely — so health officials can anticipate where resources will be needed most.

Category
Project Lead(s)
Status
In Progress

This project plans to use Georgia Tech facilities and personnel to develop, produce, and distribute RT-PCR master mix kits (reverse transcriptase and DNA polymerase enzymes), qPCR probes, and primer kits to State of Georgia Clinical Laboratory Improvement Amendments (CLIA) labs for Covid-19 testing.

For more information, please visit:

Category
Project Lead(s)
Status
In Progress

To explore the antiviral potential of Georgia Tech’s library of natural products that were previously discovered through an existing drug discovery program funded by the National Institutes of Health. These small molecules are structurally unique and not commercially available. They have structural similarities to other small molecules known to inhibit coronaviruses and may be useful in the search for Covid-19 therapeutics.

Category
Project Lead(s)

Completed Projects

This project aims to support the development of a cross-platform smartphone application for the triage and monitoring of Covid-19 patients. The team plans to do so by leveraging sensors data collected with smartphones and the existing Health Readiness and Performance System (HRAPS) cloud for machine learning and data analytics. The developing technology will also apply to the longitudinal tracking of exposure to chemical and biological threats in military environments. For now, the technology will allow doctors and healthcare facilities to manage readmissions for Covid-19 patients better, intervene on patients before they become critical with potentially life-saving implications, and reduce the burden on emergency rooms and hospitals.

Category
Project Lead(s)
  • Project details will not be shared at this time. For any inquiries, please use the contact us section on this site.
Category
Project Lead(s)

This project aims to design an emergency ventilator that could be built entirely with widely available off-the-shelf parts from hardware and auto parts stores. The design valued efficiency and simplicity in multiple areas.

  • No specialized tools, computer programming, or electronics/manufacturing skills are required.
  • The design can be built by one or two people in approximately one day.
  • The total cost is roughly $350 in parts. 

In the basic configuration, the design supports a pressure-controlled constant mandatory ventilation mode (PC-CMV), with continuous independent control of positive inspiratory pressure (PIP), positive end-expiratory pressure (PEEP), and an inhale/exhale ratio selection of either 1:1 or 3:1. 

Project Lead(s)

Support the manufacturing industry in upscaling the production of plastic nasal swabs that go into Covid-19 swab kits. Researchers teamed with Kimberly Clark, connected the company to Puritan Medical Diagnostics, and provided other "learning curve" support. The goal has been to support the manufacturers in soliciting key manufacturing expertise. The team has provided several key expert connections, so the companies can upscale their production more rapidly. Researchers have learned that the core U.S. manufacturers have the capacity to supply millions of swabs per week, but they still need to repurpose these to Covid-19 kits and break out of existing supply contracts for other supplies. Thus, the critical limitations are at the distribution level though sufficient materials exist. The effort is being handled by these manufacturers, and the team is on standby for further input as needed.

Category
Project Lead(s)